Related Experiment Video
Updated: May 23, 2026
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Treatment guidelines for gastrointestinal stromal tumors in children and young adults
Katherine A Janeway1, Alberto Pappo
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. katherine_janeway@dfci.harvard.edu
Insights
Pediatric gastrointestinal stromal tumors (GIST) exhibit unique characteristics necessitating distinct management strategies compared to adult GIST. Current guidelines for pediatric GIST diagnosis and treatment are based on existing clinical data due to the rarity of this condition in children.
Area of Science:
- Pediatric Oncology
- Gastrointestinal Pathology
- Rare Cancers
Background:
- Gastrointestinal stromal tumors (GIST) in children present with distinct biological and clinical features compared to adult GIST.
- The rarity of pediatric GIST limits the performance of prospective clinical trials.
- Existing management protocols for adult GIST may not be directly applicable to the pediatric population.
Purpose of the Study:
- To review the unique biology, clinical presentation, and natural history of pediatric GIST.
- To establish evidence-based guidelines for the diagnostic evaluation and management of GIST in children.
- To provide a framework for clinical decision-making in this rare pediatric malignancy.
Main Methods:
- Comprehensive literature review focusing on pediatric GIST cases.
- Analysis of case reports and case series to understand disease patterns.
- Synthesis of clinical experience and published data to formulate management recommendations.
Main Results:
- Pediatric GIST demonstrates a unique biological profile and natural history.
- Clinical presentation and diagnostic findings in children differ from adults.
- Data from case studies inform current understanding and management approaches.
Conclusions:
- Management strategies for pediatric GIST require adaptation due to its unique characteristics.
- Guidelines are proposed based on the best available evidence from case data and clinical expertise.
- Further research and data collection are crucial for optimizing pediatric GIST care.
Abstract:
Gastrointestinal stromal tumor (GIST) occurring in the pediatric population has a unique biology and natural history when compared to GIST occurring in adults. As a result of these unique features, management of GIST in children may need to differ from management of GIST in adults. GIST is a very rare disease in children. Consequently prospective clinical trials have not been performed. A review of the biology, clinical presentation and natural history of GIST in children is presented. Guidelines for diagnostic evaluation and management of GIST in children are presented. The presented guidelines are based on clinical experience and data from case reports and case series.
